Vaccin - activities

Covid vaccination: 80.6 % of French people vaccinated for the first time, 60.5 % received the booster dose

At Monday July 10th, 2023, 80.6 % of the French population received at least one dose of vaccine, and 79.2 % of them received a complete vaccination schedule. 60.5 % of the French population received a booster dose.

Covid: three Omicron-specific vaccines approved by the French Health Authority

As an umpteenth Covid wave threatens France this Fall, the French Health Authority (HAS) announced this Tuesday September 20, 2022, they approved the issuance in France of three Omicron-specific vaccines to effectively fight against the virus and transmission. “Bivalent” vaccines developed by Pfizer/BioNTech and Moderna, all three approved earlier by the European Medicines Agency.

Covid: Sanofi's vaccine soon to be allowed in Europe

Is the Sanofi vaccine soon to be marketed? This Tuesday July 20, 2021, the European Medicines Agency has announced they are to launch a rolling review of results from phase 3 of the ongoing clinical trial of the French laboratory candidate vaccine in order to allow or not marketing issuance as soon as possible. Issuance could actually occur in the first six months of 2022, although it has been announced for late 2021.

Covid: The first deliveries of the Novavax vaccines planned for the end of the week in France

Granted marketing authorizatoin by the European Medicines Agency and the Haute Autorité de Santé, Nuvaxovid, aka Novavax's "subunit" vaccine, which was expected to be delivered in France as early as the beginning of February, is eventually to be delivered by the end of the week.

Covid: WHO thinks it is “premature” to declare victory over coronavirus

This Tuesday February 1, 2022, the World Health Organization warned against the too-hasty lifting of restrictions. According to Tedros Adhanom Ghebreyesus, it is too early to declare victory.

Covid: intranasal vaccine by the Inrae and the Tours University still under rolling review

Is a genuinely effective intranasal covid vaccine soon to be available? This is what searchers from the Inrae and the Tours University say as they registered a patent on Thursday September 9, 2021 as for a candidate vaccine that led to promising results on animals, including a 100% effectiveness, according to scientists. But where are the clinical trials at? Keep reading to find out more.

Covid: what is the nocebo effect explaining 76% of the vaccine’s side effects?

An American study explains 76% of side effects felt after the injection of the first dose of Covid vaccine are caused by the nocebo effect. But then, what is the nocebo effect?

Coronavirus: vaccine pass from January 24 and exceptions for 1st doses

The coronavirus epidemic goes on in France. As the Constitutional Council is to release their report on the vaccine pass this Friday, the government addressed the transformation of the health pass during a conference delivered by Prime Minister Jean Castex and Health minister Olivier Véran this Thursday. Therefore, we have been told, it will come into effect this Monday January 24, 2022.

Covid: faced with the Delta variant, a passed infection protects more than vaccination

An American study issued this Wednesday January 19, 2022, shows non-vaccinated people who had Covid in the past are better protected against the Delta variant than people who have been vaccinated only. Yet, “vaccination remains the safest strategy”, the U.S. health authorities specify.

Covid: Pfizer’s Omicron vaccine to be ready in March

This Monday January 10, 2022, Pfizer announced their new version of the vaccine targeting the Omicron variant will be ready in March.

Covid: Do first Janssen-vaccinees need a third dose?

Janssen vaccine was distinguishing itself because it only requires one jab, enough to be protected against Covid-19. The health authorities decided a second dose was necessary at least four weeks after the first one. Is a third dose needed like for the other jabs? Keep reading to find out more.

Covid: isolation rules to be relaxed from Monday January 3rd

New isolation rules will be instated from January 3 for all contact cases and Covid-19 sick with different modalities depending on the vaccination scheme.

Covid: a fourth dose of vaccine? “It is a possibility”, Olivier Véran claims

At the end of the latest press brief held this December 27, 2021, Health Minister Olivier Véran claimed a fourth dose of Covid-19 vaccine was a “possibility” in France.

Omicron: immunity drops 10 weeks after the third dose, a UK study found

As the third dose vaccination campaign is going on in France, the UK health security agency has released a study showing immunity drops only ten weeks after the booster. Towards a fourth dose?

Covid: Pfizer to vaccinate children under 5 in 2022

After 5-11 years old, drugmaker Pfizer now wishes to vaccinate children under 5 years of age. They announced tests have already begun and they will seek approval by mid-2022.

Coronavirus: vaccinating children at risk, and 5-11 y.o. children

As France is experiencing an increase in coronavirus contaminations, the government announced the opening of vaccination to children under 12 by the end of the year. For the most fragile ones, slots open from December 15, 2021.

Covid - Omicron variant: Pfizer vaccine 70% effective against severe disease, a study found

According toa South-African study carried out by the South African Medical Research Council, the Pfizer vaccine is 70% effective against the Covid Omicron variant, although it is still more resistant, according to a study carried out by the Africa Health Research Institute from Durban. Keep reading to find out more!

Covid: a booster shot 3 months past the latest injection “safe and effective”, the EMA says

This Thursday, the European Medicines Agency announced booster shots can be given in a “safe and effective” fashion only three months past the latest injection.

Omicron: “partial decrease in the vaccine” effectiveness, but “results need confirmation”

According to Pr. Anne-Claud Crémeiux, vaccines are partially less effective against the new Omicron variant, a study found.

Covid: vaccines’ effectiveness, severe disease… The WHO intends to reassure about the Omicron variant

As many countries are making more health measures to face the Omicron variant, the OMS tries to reassure. According to one of the Organization seniors who spoke to the AFP, there is “no reason” to think the current vaccines do not protect against the variant found for the first time in South Africa. Furthermore, the Omicron does not “cause more severe illness”.